What type of organism is Enterobacter cloacae when isolated from a sputum culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Enterobacter cloacae Classification

Enterobacter cloacae is a Gram-negative, facultative anaerobic, rod-shaped bacterium belonging to the Enterobacteriaceae family 1, 2.

Organism Characteristics

When isolated from sputum culture, E. cloacae represents a Gram-negative aerobic pathogen that falls within the broader category of Enterobacteriaceae 1. This classification is clinically significant because:

  • It is a facultative anaerobe, meaning it can survive in both aerobic and anaerobic conditions 2
  • Rod-shaped (bacillus) morphology on Gram stain 2
  • Part of the Enterobacteriaceae family, which includes other common nosocomial pathogens like E. coli and Klebsiella 1

Clinical Significance in Respiratory Specimens

When E. cloacae is Pathogenic

According to guideline evidence, Gram-negative aerobic pathogens (including Enterobacteriaceae) obtained from bronchoalveolar lavage or sputum samples are considered indicative of true pathogens causing lung infiltrates 3. This is particularly relevant in:

  • Febrile neutropenic patients with lung infiltrates 3
  • Ventilator-associated pneumonia (VAP) - E. cloacae causes VAP with high mortality (24%), predominantly affecting women and patients with translaryngeal endotracheal tubes 4
  • Healthcare-associated infections - especially in patients with chronic or previously treated infections 1

Important Clinical Context

E. cloacae in sputum may represent colonization rather than true infection in certain scenarios. The distinction depends on:

  • Clinical context: Presence of fever, infiltrates on imaging, elevated white blood cell count
  • Specimen quality: Sole or predominant organism on culture with corresponding Gram stain findings suggests true pathogen 1
  • Patient risk factors: ICU admission (78% of E. cloacae pneumonia cases), mechanical ventilation (97% of ICU cases), immunodeficiency (54%), and prior surgical procedures 4

Resistance Patterns

E. cloacae has chromosomal AmpC β-lactamase that is inducible, leading to resistance against oxyimino-β-lactams (like ceftazidime, cefotaxime) but typically remaining susceptible to carbapenems 5. However, carbapenem-resistant strains including those producing NDM-1 have been reported 6.

Common Pitfalls

  • Do not dismiss E. cloacae as mere colonization without clinical correlation - it causes genuine pneumonia with 24% mortality in VAP cases 4
  • Avoid assuming susceptibility to third-generation cephalosporins - the organism has inducible resistance mechanisms 5
  • Consider cross-contamination sources - E. cloacae can spread via contaminated medical equipment like transesophageal echocardiography probes 7

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
What is the appropriate treatment for transverse low‑grade colitis in an adult?
What is the appropriate first-line antihypertensive medication for a 61-year-old patient with an estimated glomerular filtration rate of 50 mL/min/1.73 m²?
Is a strong anti‑mitochondrial (anti‑M2) antibody result clinically significant for diagnosing primary biliary cholangitis despite normal C‑reactive protein, normal erythrocyte sedimentation rate, low‑titer antinuclear antibody with nuclear‑cytoplasmic pattern, and negative ANCA, anti‑nucleosome, anti‑double‑stranded DNA, and anti‑ENA antibodies?
Can ropinirole be taken multiple times daily, and what are the appropriate dosing regimen and potential side effects?
What are the therapeutic indications for imipramine?
Why should hydrochlorothiazide be avoided in a 61-year-old patient with an eGFR of 50 mL/min/1.73 m²?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.